2019 Medicare Part D Opioid Policies: Information for Prescribers
Customize your policy alerts
Sign up for all network_health policy alerts
Know when network_health releases new policies or updates existing guidance.
Monitor payer policy activity
Describes CMS-required Medicare Part D opioid safety alerts, supply limits for opioid-naïve patients, MME-based care coordination alerts, prescriber responsibilities, and drug management program (DMP) procedures affecting Medicare Part D beneficiaries and their prescribers.
No material clinical or coverage changes in this revision.
Coverage & Utilization Management
Utilization management rules
Coverage and utilization management actions that Part D plans may apply
Residents of long-term care facilities, patients in hospice, patients receiving palliative or end-of-life care, and patients being treated for active cancer-related pain are exempt from the Part D opioid safety interventions described in this policy. These exemptions mean that the utilization management rules (including initial supply limits, pharmacy safety alerts, and enrollment in Drug Management Programs) do not apply to those groups.
Plans must still ensure access to appropriate therapy for exempt patients; the policy does not change coverage for medically necessary opioid treatment in these circumstances and should not interfere with access to medication-assisted treatment (e.g., buprenorphine) where clinically indicated.
Thresholds, Limits, and Definitions
Initial Opioid Dispensing Rules
Initial opioid supply limits
Initial dispensing for opioid‑naïve patients
Implemented as a hard edit at dispensing in Part D plans.
Prescriber & Pharmacy Responsibilities
Prescriber may request standard or expedited coverage determination
On the patient’s behalf the prescriber has the right to request a coverage determination — either standard or expedited — to override dispensing edits or obtain the full days’ supply as written. The prescriber may request this determination in advance of prescribing an opioid.
Directed prescriber and/or pharmacy requirement (DMP)
Plans may require patients identified as at‑risk to obtain opioids and benzodiazepines from a specified prescriber and/or a specified pharmacy as part of a Drug Management Program (DMP). These directed prescriber/pharmacy requirements can be implemented as coverage limitation tools or individualized point‑of‑sale edits.
Prescriber attestation and pharmacist outreach
Prescribers must attest to the plan that the days’ supply (including the 7‑day initial supply for opioid‑naïve patients) is the intended and medically necessary amount; pharmacists and plans may contact the prescriber to resolve safety alerts and prescribers should respond in a timely manner.
- Attestation is required for the identified cumulative MME level to allow dispensing.
- Once a pharmacist consults with a prescriber for a plan year, the prescriber will generally not be contacted on every subsequent opioid prescription for that patient unless further restrictions are implemented.
Drug Management Program coverage limitations and notification requirements
DMPs may limit coverage to specified prescribers/pharmacies or apply individualized POS edits for patients the plan identifies as at‑risk; plans will perform case management, notify the patient in writing (and make reasonable efforts to notify the prescriber) before imposing limits, and may impose limits for 12 months (extendable to 24).
- Potentially at‑risk patients are identified by use involving multiple prescribers and/or pharmacies.
- After case management and a 30‑day notification period, plans send a second written notice confirming the specific limitation and duration if a limitation is implemented.
- Patients and prescribers retain the right to appeal DMP coverage limitation decisions.
Policy Background
CMS implemented new Medicare Part D opioid safety policies effective January 1, 2019 to reduce opioid overutilization. The policies require improved pharmacy safety alerts at dispensing and allow Part D plans to establish drug management programs for beneficiaries deemed at-risk for misuse or abuse.
The intent of these changes is to support prescribers and pharmacists in identifying potential safety issues at the point of dispensing and to provide care coordination tools for patients at higher risk, while preserving access to necessary treatments.
Key Terms
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.